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Objective: To investigate the protective effect of green tea epigallocatechin gallate (EGCG) on long-term
ketamine-induced ulcerative cystitis (KIC) using a ketamine addiction rat model.
Materials and methods: Thirty Sprague-Dawley rats were divided into three groups which received sa-
line, ketamine (25 mg/kg/d), or ketamine combined with EGCG (10 mM/kg) for a period of 28 days. In
each group, cystometry and a metabolic cage micturition pattern study were performed weekly. Mas-
son's trichrome study was done to evaluate the morphologic changes. Western blot analyses were carried
out to examine the expressions of inﬂammatory protein [transforming growth factor-b (TGF-b)] and
ﬁbrosis proteins (ﬁbronectin and type I collagen) in bladder tissues.
Results: Chronic ketamine treatment resulted in bladder hyperactivity with a signiﬁcant increase in
micturition frequency and a decrease in bladder compliance. These alterations in micturition pattern
were accompanied by increases in the expressions of inﬂammatory and ﬁbrosis markers, TGF-b, ﬁbro-
nectin, and type I collagen after long-term ketamine treatment. Masson's trichrome stain showed that
ketamine treatment decreased urothelium thickness while increasing the collagen to smooth muscle
ratio and exacerbating interstitial ﬁbrosis. By contrast, simultaneous EGCG and ketamine treatment
reversed ketamine-induced damage to almost control levels, showing the protective effect of EGCG.
Conclusion: This protective effect of EGCG may come from its antiinﬂammatory and antiﬁbrotic
properties.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Recently, several studies have demonstrated that ketamine
addition affects the urinary bladder, resulting in an increase of
urination frequency, urgency, nocturia, hematuria, and painful
micturition.1e3 Traditionally, ketamine has been used for inductionllege of Medicine, Kaohsiung
, Kaohsiung City 807, Taiwan.
ipt.
ociation. Published by Elsevier Taof anesthesia. How ketamine induces bladder damage remains
unclear; however, formation of an active metabolite of ketamine
might result in such urinary tract damage. It is plausible that ke-
tamine and its metabolites accumulate in the urine and induce
signiﬁcant bladder irritation. The higher concentration and the
longer time ketamine metabolites remain in the bladder might
cause direct toxic effects on the bladder interstitial cells and trigger
mucosal and submucosal inﬂammatory responses.4
Several pathological conditions of the urinary bladder are
associated with the formation of reactive oxygen species (ROS) and
reactive nitrogen species (RNS) with increased oxidative stress.5e7iwan LLC. This is an open access article under the CC BY-NC-ND license (http://
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matory changes, both ROS and RNS are increased. Our recent work
also showed an increase in oxidative stress in ketamine-induced
ulcerative cystitis (KIC).8
Green tea is a popular health drink worldwide. Previous studies
have identiﬁed strong antiinﬂammatory/antioxidant properties of
green tea and its associated polyphenols. Green tea contains several
polyphenolic compounds, including epigallocatechin gallate
(EGCG), epigallocatechin (EGC), epicatechin gallate, and epi-
catechin. Many studies have suggested that the biological activity of
green tea is mediated by its major polyphenolic compound, EGCG.9
This compound can prevent and/or reduce the deleterious effects of
oxygen-derived free radicals associated with various chronic dis-
eases, such as neurodegenerative disorders.10,11 Many studies have
indicated that green tea could offer a potential dietary protection
against numerous cancers and have activities in bladder tumor
inhibition in different animal models and clinical trials.12e14
Our previous study has shown EGCG could ameliorate
ovariectomy-induced overactive bladder (OAB) symptoms through
decreasing bladder intramural nerve damage and diminishing M2
and M3 muscarinic receptor overexpression.15,16 To investigate the
mechanism of stimulation of ﬁbrosis production in KIC, we deter-
mined the amounts of transforming growth factor beta (TGF-b),
type I collagen- and ﬁbronectin-speciﬁc protein in control,
ketamine-treated, and ketamine combined with EGCG-treated
bladder tissue samples. The aim of this study was to evaluate
whether green tea extract, EGCG, could prevent KIC through less-
ening oxidative stress and decreased interstitial ﬁbrosis underlying
the response to ketamine addition in a rat model.
2. Materials and methods
2.1. Animals and ketamine administration
Experiments were performed on 36 adult female Sprague-
Dawley rats (animal center of BioLASCO, Taipei, Taiwan) weighing
between 200 g and 250 g. These rats were housed under a 12-hour
light/dark cycle with free access to food and water at 21oC. Thirty
Sprague-Dawley rats were divided into three groups. Twelve rats
received intraperitoneal (IP) injection of saline (0.5 mL, control
group), 12 received ketamine daily injection (25 mg/kg/d diluted in
0.5 mL saline), and 12 received a daily injection of ketamine and
EGCG, 10 mM/kg IP, over a period of 1 month. EGCG was initially
dissolved in dimethyl sulfoxide at a concentration of 10 mmol/L.
This study was approved by the Animal Care and Treatment Com-
mittee of Kaohsiung Medical University. All experiments were
conducted according to the guidelines for laboratory animal care.
All efforts were made to minimize animal stress/distress.
2.2. Metabolic cage study and data analysis
The rats were placed in individual R-2100 metabolic cages (Lab
Products, Rockville, MD, USA). After this time, a known volume of
water was measured and placed in the drinking bottles of the an-
imals. Micturition frequency and urine output were determined
using a cup especially ﬁtted to an FT03 force transducer (Grass
Technology, Warwick, RI, USA). The volume of liquid consumed, 24-
hour micturition frequency, and urine production were recorded
for 3 days and an average value was determined.
2.3. Cystometrogram and data analysis
Cystometry was performed before euthanizing the animals. The
cystometrograms (CMGs) were carried out according to themethod
previously described.17 In brief, in each experiment, rats wereanesthetized with Zoletil-50 (1 mg/kg IP injection). Before the
beginning of each CMG, the bladder was emptied; a polyethylene-
50 catheter from the urethra was inserted into the bladder and was
connected via a T tube to a pressure transducer and a microinjec-
tion pump (CH-4103, Infors, Bottmingen, Switzerland). Then, the
bladder was infused with saline at a steady rate (0.08 mL/min). A
voiding contraction was deﬁned as an increase in bladder pressure
that resulted in urine loss. CMG was recorded until the bladder
pressure was stable and at least ﬁve ﬁlling/voiding cycles were
measured on each rat. CMG parameters recorded for each animal
included peak micturition pressure, bladder volume, the frequency
of voiding contractions, and the frequency of nonvoiding contrac-
tions (without urine leakage during bladder infusion).18
2.4. Histological study and collagen/detrusor smooth muscle ratio
After cystometric studies, experimental rats were perfused with
a saline solution through the left ventricle. The bladders were then
removed, cut open, and further ﬁxed overnight. The tissue samples
were embedded in parafﬁn blocks with the same area in different
groups, and serial sections 5-mm thick were obtained. Deparafﬁ-
nized sections were stained with Masson's trichrome stain (Sigma-
Aldaich, St. Louis, MO, USA, Masson's trichrome Stain Kit HT15). The
standard Masson's trichrome staining procedure, which stains
connective tissue blue and detrusor smooth muscle (DSM) red, was
performed. The urothelial thickness was compared between groups
according to the layers of urothelial cells, and the connective tissue
distribution was compared between groups. Each specimen was
captured using a digital camera in ﬁve random nonoverlapping
frames at 400 magniﬁcation. The color setting and the image-
associated quantiﬁcation were determined using image analysis
software (Image-Pro Plus, Rockville, MD, USA, Media Cybernetics,
MD, US). The blue-stained collagen and the red-counterstained
DSM were highlighted in each image. The total areas occupied by
collagen and DSMwere then determined, and the ratios of collagen
to DSM (collagen/DSM) were calculated. The histology slides were
reviewed by two different pathologists who were unaware of the
experimental groups.
2.5. Protein isolation and Western blot analysis for inﬂammatory
and ﬁbrosis markers
Frozen tissues of bladder were homogenized on ice in the buffer
containing the Halt Protease Inhibitor Cocktail (Pierce, Rockford, IL,
USA) at 100 mg/mL. Protein concentration in the supernatant was
determined using the bicinchoninic acid protein assay (Pierce)
against a bovine serum albumin protein standard. An equal amount
of protein (30 mg) from the bladders was loaded on sodium dodecyl
sulfate polyacrylamide gel electrophoresis gels and transferred to
polyvinylidene ﬂuoride (Immobilon-P, Millipore, Billerica, MA,
USA) membranes with Towbin buffer. Immobilon-P membranes
were then blocked and incubated with the primary antibody.
Monoclonal antibodies to TGF-b (R & D, Minneapolis, MN, USA,
1:1000), ﬁbronectin (BD, Franklin Lakes, New Jersey, USA, 1:1000),
type 1 collagen (Abcam, Cambridge, MA, USA, 1:1000), and cyclo-
oxygenase-2 (COX-2) (Cayman, Ann Arbor, Michigan, USA, 1:1000)
were used to determine the changes in the expressions. COX-2 was
used to determine the changes in inﬂammatory markers; TGF-b,
ﬁbronectin, and type 1 collagen were used to determine the
changes in interstitial ﬁbrosis. In each experiment, negative con-
trols without the primary antibody and protein molecular weight
markers were carried out to exclude nonspeciﬁc bands. Band in-
tensity was normalized with respect to Glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH) (Upstate Signaling, Charlottesville,
VA , USA, 1:5000). After treatment with the primary antibody,
Fig. 1. Effects of ketamine treatment on cystometric parameters and voiding behavior in different groups. (A) Cystometry recordings illustrated micturition pressure and voiding
frequency, including voiding contractions (arrows) and non-voiding contractions (stars) on anesthetized rats. (B) Voiding behavior evaluated by metabolic cage voiding diary as
voided volume. (C-E) Trace recordings illustrating voided frequency (C), voided volume (D) and maximal voiding pressure (E) were calculated for different groups. Each bar was the
mean ± standard deviation (SD) of the mean for n ¼ 10. *Indicates signiﬁcant difference from the control (saline) group (p < 0.05). **Indicates signiﬁcant difference from the control
(saline) group (p < 0.01).
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Table 1
General characteristics and urodynamic parameters between different experimental
groups.
Saline Ketamine Ketamine þ EGCG
No. of rats 12 12 7
General characteristics
Body weight (g) 276.0 ± 17.2 260.0 ± 14.2 268.0 ± 15.8
Bladder weight (mg) 112.0 ± 13.8 128.0 ± 16.0* 116.0 ± 14.6
Urodynamic parameters
Frequency
(no. voids/60 min)
3.2 ± 0.6 13.7 ± 3.8** 4.0 ± 0.7
Voiding pressure (cm H2O) 31.3 ± 3.8 48.6 ± 3.7** 36.4 ± 4.4*
Voided volume (mL) 1.76 ± 0.28 0.67 ± 0.13** 1.26 ± 0.34*
No. of nonvoiding
contractions
between micturition
(no./60 min)
0 3.7 ± 0.50** 0
Water intake (mL)/24 h 32.6 ± 4.6 31.0 ± 4.3 32.4 ± 4.8
Urine output (mL)/24 h 26.5 ± 3.5 25.2 ± 3.9 30.5 ± 5.2
Data are presented as mean ± standard error.
*p < 0.05.
**p < 0.01.
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secondary antibody (goat anti-mouse IgG). The expression of the
protein band was visualized by adding ECL-Plus (Amersham Phar-
macia Biotech, Piscataway, NJ, USA) for 1e2 minutes. The mem-
brane was sealed in a hybridization bag, scanned, and analyzed
using a Kodak, Rochester, NY , USA Image Station 440CF and Kodak
ID image analysis software.
3. Results
3.1. The effects of ketamine and EGCG treatment on cystometric
parameters
CMG parameters recorded micturition pressure, micturition
frequency, voiding contractions, and nonvoiding contractions as
shown in Fig. 1. Ketamine-injected rats showed bladder hyperac-
tivity with increases in voiding contractions (arrows) and non-
voiding contractions (stars), micturition frequency, and micturition
pressure (Figs. 1A and 1B). There was a signiﬁcant decrease in
micturition interval and increase in micturition pressure (1.6-fold;
Figs. 1A and 1C) and micturition frequency (2.3-fold) compared
with the saline (control) rats (Figs.1B and 1D). Fig.1C demonstrated
that maximal micturition pressure (pdt max) was signiﬁcantly
increased by ketamine treatment. Moreover, bladder volume was
also signiﬁcantly decreased in the ketamine group (p < 0.01 in
comparison with the control; Fig. 1D). However, treatment with
EGCG signiﬁcantly attenuated the frequency of nonvoiding con-
tractions (Figs. 1A and 1D) and maximal micturition pressure
(Figs. 1A and 1C), but increased bladder volume (Figs. 1B and 1D)
compared with the ketamine group. The voiding pattern and
bladder volume were similar to the control and showed good
storage and emptying functions.
3.2. Tracing analysis of voiding behavior and bladder storage
Table 1 shows tracing analysis of voiding behavior by metabolic
cage. On tracing analysis, ketamine treatment increasedmicturition
frequency and lessened voiding volume compared with the saline
rats. These results demonstrated that ketamine treatment impaired
bladder storage function. However, EGCG treatment improved
bladder storage functionwith decreased micturition frequency and
increased voiding volume compared with the ketamine rats
(Table 1).3.3. The histological features of ketamine-associated bladder
damage
The histological features of ketamine-associated bladder dam-
age were analyzed using Masson's trichrome stain. In the control
group (Figs. 2A and 2A0), there were three to ﬁve layers of uro-
thelium (black star) and only sparse collagen (blue color) distrib-
uted between the smooth muscle bundles (Fig. 2A0). In the
ketamine group (Figs. 2B and 2B0), the bladder tissues were char-
acterized by ulcerated mucosa with a thinner layer of epithelial
cells (black star), erythematous patches, and increased interstitial
ﬁbrosis stained in dark blue (black arrow) between the DSM bun-
dles were shown prominently. However, after EGCG administration
(Figs. 2C and 2C0), the thickness of urothelium (star) increased to
three layers (black star), and interstitial ﬁbrosis decreased (black
arrow). In Fig. 3, the ratio of collagen to DSM showed that ketamine
injection over 1 month signiﬁcantly increased the severity of
interstitial ﬁbrosis (p < 0.01 in comparison with the control),
whereas EGCG administration lessened interstitial ﬁbrosis and
erythematous patches.
3.4. The effects of ketamine and EGCG treatment on ﬁbrosis marker
expression
To investigate the ﬁbrosis process after ketamine treatment or
with EGCG, the expressions of TGF-b, ﬁbronectin, and type I
collagen at protein level were examined using Western blotting.
The results showed that TGF-b (11.5-fold; Fig. 3A), ﬁbronectin (5.0-
fold; Fig. 3B), and type I collagen (11.2-fold; Fig. 3C) expressions
were signiﬁcantly increased 1 month after ketamine administra-
tion. In addition, treatment with EGCG signiﬁcantly decreased TGF-
b (3.8-fold; Fig. 3A), ﬁbronectin (1.9-fold; Fig. 3B), and type I
collagen (5.5-fold; Fig. 3C) expressions compared with ketamine
rats. These ﬁndings showed that administration of EGCG reduced
the ﬁbrotic biosynthesis and protected the bladder from ketamine-
induced inﬂammatory damage.
4. Discussion
In the present study, we demonstrated that ketamine injection
signiﬁcantly increased bladder overactivity 28 days later. These
results demonstrated that ketamine treatment caused bladder
hyperactivity by altering maximal micturition pressure, increased
micturition frequency, enhanced bladder nonvoiding contraction,
and lessened bladder capacity. By contrast, EGCG administration
improved voiding pattern and bladder capacity. Ketamine treat-
ment signiﬁcantly decreased urothelial thickness, increased sub-
urothelial hemorrhage, and enhanced interstitial ﬁbrosis;
however, EGCG treatment reversed these changes to near the
control levels.
In the present study, ketamine addition was related to a
signiﬁcantly greater collagen/smooth muscle (SM) ratio, which
was compatible with previous studies.19,20 These histological
changes might be associated with decreased bladder compliance
and bladder capacity as demonstrated in urodynamic studies.
Investigations have associated bladder wall mechanical proper-
ties with detrusor muscle elasticity, content of collagen, and
collagen distributions.19 In studying dysfunctional bladders,
Landau et al21 showed dysfunctional bladders were signiﬁcantly
less compliant than normal controls, and these bladders have
increased collagen deposition and collagen/SM ratios. These
pathological ultrastructural changes were reﬂected by abnormal
low bladder volume and decreased bladder compliance, and
these could be indicators for a loss of bladder wall elasticity.
Fig. 2. Representative microphotographs of (A) control group, (B) ketamine group and (C) ketamine-combined EGCG groups as shown by Masson's trichrome staining. (D) The ratio
of collagen to smooth muscle. The blue-stained collagen and red-counterstained smooth muscle (SM) were highlighted for each image. The total areas occupied by SM and collagen
were calculated. Scale bar represents the unit of 50 mm. Each bar represents the mean ± SD of the mean for n ¼ 10. *Indicates signiﬁcant difference from the control (saline) group, p
< 0.05; ** Indicates signiﬁcant difference from the control (saline) group, p < 0.01.
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more elastic properties and higher compliance than bladders
with a higher proportion of collagen. EGDG treatment reversed
collagen/SM ratios, lessened interstitial ﬁbrosis level, and
restored bladder storage function.
In ketamine-treated bladders, TGF-b expression was signiﬁ-
cantly increased when compared with the control. TGF-b is a
multifunctional growth factor involved in the cell differentiation,
proliferation, and extracellular matrix remodeling after binding
with cell surface receptors for TGF-b.22 In obstructive renal disease,
increased TGF-b expression has led to enhanced macrophage
inﬁltration, myoﬁbroblast formation and type I collagenaccumulation.23,24 Our previous study demonstrated that there are
increased ﬁbronectin and type I collagen expressions in ovariec-
tomized bladders,15 showing that these proﬁbrotic and ﬁbrosis
markers are important in bladder interstitial ﬁbrosis and are the
pathophysiological mechanisms underlying OAB.
EGCG is the major constituent and displays the most potency in
the inhibition of cell growth. In the present study, EGCG treatment
could ameliorate ketamine-induced TGF-b overexpression. Another
study also mentioned that EGCG could ameliorate the over-
production of proinﬂammatory cytokines and mediators, reduce
the activity of nuclear factor-kB (NF-kB), inhibit the expression of
inducible nitric oxide synthase, and reduce the inﬂammatory
Fig. 3. The effects of ketamine and epigallocatechin gallate (EGCG) treatment on proﬁbrotic and ﬁbrosis marker expressions. Representative Western blots of bladder tissue ho-
mogenate probed with (A) an antibody speciﬁc to transforming growth factor-b (TGF-b), (B) ﬁbronectin, and (C) type I collagen in each group. Quantiﬁcations of the ratios of TGF-b,
ﬁbronectin, and type I collagen expressions to actin are shown in the lower of the top ﬁgures. Results are normalized as the control ¼ 100%. Each bar is the mean ± standard
deviation (SD) of the mean for n ¼ 8. *Indicates signiﬁcant difference from the control (saline) group, p < 0.05; ** Indicates signiﬁcant difference from the control (saline) group, p <
0.01. GADPH ¼ glyceraldehyde 3-phosphate dehydrogenase.
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bladder damage through multifunctional activities. Firstly, EGCG
is a powerful hydrogen-donating antioxidant, a free radical scav-
enger of ROS and RNS. EGCG could accumulate in the mitochondria
where it acted locally as a free radical scavenger. Then, the pro-
tective effect of EGCG may involve the regulation of naturally
occurring antioxidant protective enzymes. EGCG was found to
elevate the activity of two major ROS metabolizing enzymes, su-
peroxide dismutase and catalase,26 thus protecting tissues from
oxidation injuries. Third, EGCG may modulate cell survival/death
genes.
In diabetic mice, EGCG signiﬁcantly increased the immunore-
activity of Ki-67 (cellular marker for proliferation), CD-31 (used
primarily to demonstrate the presence of endothelial cells and
evaluate the degree of angiogenesis), and a-smooth muscle actin
expressions. These results suggest that EGCG could beneﬁt wound
healing by accelerating re-epithelialization and angiogenesis. In
addition, several reports have shown that EGCG was a powerful
hydrogen-donating antioxidant and free radical scavenger of ROS
and RNS. EGCG can inhibit iron ascorbate-induced mitochondrial
membranes and synaptosomes lipid peroxidation,27,28 thus pro-
tecting brain tissue from free radical damages.
5. Conclusion
This preliminary study showed that EGCG had protective effects
on KIC and OAB symptoms. This protective mechanism may arise
from reducing proﬁbrotic markers and lessening interstitial
ﬁbrosis. However, further studies for investigating the protective
effects of EGCG on bladder tissues are required to elucidate the
underlying mechanisms and signal pathways.
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